The Valley Desk

NCT00057720 · Interventional trial

TLK286 (Telcyta) vs. Doxil/Caelyx or Hycamtin in Platinum Refractory or Resistant Ovarian Cancer

Overall registry status Completed

Phase 3

Conditions Ovarian Neoplasms

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov